Our new report discusses issues and events affecting the medical infusion devices market. You will find discussions, including qualitative analyses.
The world infusion pump market is on the rise. In 2016, the market was worth an estimated $8.54bn with steady growth projected for the next decade. The advent of modern technology has driven growth in this segment through innovation, while an increasing patient base and increasing healthcare expenditure in emerging markets counties to spur growth. In this report we assess the global infusion pumps market by nation, as well as the individual submarkets within it. Submarkets of interest include insulin pumps for the treatment of diabetes, chemotherapy pumps for oncology therapeutics, and eternal feeding pump to provide nutrition. An overview of the major global drug delivery market will also be provided, along with a ten year financial forecast. In addition, the report will analyse the leading products on the market, the infusion pump R&D pipeline, and the competitive landscape in order to provide a comprehensive overview of the forces at work within the world infusion pump industry.
Forecasts in that Study – Overall World Market, Submarket, Product and Country Discover in our report overall world revenue to 2026 for Infusion Devices Market. Also explore individual revenue predictions to 2026 for five therapeutic submarkets at world level: • Insulin pumps • Enteral feeding pumps • Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)
How will individual drug delivery sub markets perform from 2016 to 2026 at world level? Our study forecasts revenues of three brands sold by four companies: • Oral drug delivery • Inhalation drug delivery • Injectable/implantable drug delivery • Transdermal drug delivery • Ocular drug delivery • Nasal drug delivery
Our work also shows individual revenue forecasts to 2026 for 12 national markets: • United States (US) • Japan • EU leaders – Germany, France, the UK, Italy and Spain (EU5) • BRIC nations – Brazil, Russia, India and China. • South Korea
There discover how high sales can go, finding submarkets, products, countries and years with highest predicted revenues. Also examine competition. Hear what’s happening, also understanding challenges, trends, competitors and opportunities.
Why should you read this report This comprehensive report will: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximise profitability for your company.
How This Report Delivers This report delivers added value by providing this analysis: • Infusion pump therapies forecasting and discussions covering the period 2016 to 2026 • Product level analysis of clinical trial data, safety and efficacy, patent protection status, and sales forecasts to 2026 • Product submarket, regional, and national market forecasts and discussions to 2026 • Visiongain interviews with authorities on the industry • Analysis of the strengths and weaknesses of the Infusion pumps market, together with the opportunities available and the threats to be overcome • Analysis of technological developments, economic, political and social factors affecting the Infusion pumps market from 2016.
Benefit your work now through our updated study, gaining original industry and market analysis: • Explanation of political, regulatory and technical factors to consider • Submarket forecasts for 2015 to 2026 • Full transcripts of exclusive Visiongain interviews with key opinion leaders in the market • Profiles of leading companies operating within the market • SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced • Porter’s Five Forces Analysis • Conclusions and recommendations
Main questions answered by this analysis • How is the infusion pump market evolving? • What is driving and restraining the infusion pumps market? • What are the market shares of the leading segments of the infusion pumps market in 2015? • How will each infusion pumps submarket grow over the forecast period and how much revenue will these submarkets account for in 2026? • How will the market shares for each infusion pumps submarket develop from 2015-2026? • What is the value of the leading infusion pumps segments in important regions of the world? • Which individual products will prevail and how will these shifts be responded to? • What will be the main driver of the overall market from 2015 to 2026? • How will political and regulatory factors influence the regional markets and submarkets? • Will leading national infusion pump markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the leading national markets change by 2026 and which country will lead the market in 2026? • How will the industry evolve during the period between 2016 and 2026? • Visiongain understands that the infusion pumps market will register strong growth. This report examines in detail the market by region, by submarket, and as a whole, and provides the reader with a thorough overview of the market to identify key growth areas and business opportunities to exploit. This is where Visiongain adds value.
Who is that study for? World Infusion Devices Market 2016-2026: Forecasts for Insulin Pumps, Enteral Feeding Pumps, other Infusion Pumps for Insulin Infusion, Drug Delivery, Oncology, Antibiotics, Analgesia, Hydration, Immune Globulin Intravenous, Chelation Therapy and Immune Globulin Subcutaneous Therapy will prove invaluable for anyone wanting to better understand the industry and its underlying dynamics. It will prove useful for businesses who wish to expand into different sectors or explore a new region for expansion of their existing operations. The report comprehensively lays out the market drivers, restraints, forecasts, technologies, investments, risks and trends to help the reader formulate a better-informed business strategy. This report will be ideal for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, Directors and others. Furthermore, governments, agencies and organisations will also find value in our research report.
How does World Infusion Devices Market 2016-2026: Forecasts for Insulin Pumps, Enteral Feeding Pumps, other Infusion Pumps for Insulin Infusion, Drug Delivery, Oncology, Antibiotics, Analgesia, Hydration, Immune Globulin Intravenous, Chelation Therapy and Immune Globulin Subcutaneous Therapy report help you? How this 250 page report delivers: • Revenues for the Global Infusion Device market to 2026 – assess that overall world infusion device market’s potential and get forecasted revenues for the leading sub-classes: Insulin Infusion, Enteral Feeding, Chemotherapy Pumps • National market forecasting to 2026 for 12 countries in the Americas, Europe and Asia – explore the best regions for treatment demand, sales and growth • Companies, news and opinions – examine participants, including Roche, Johnson & Johnson, Sanofi and Medtronic among others • Analysis of what stimulates and restrains that industry and market – assess challenges and strengths there, helping you compete and gain advantages.
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 World Infusion Pumps Market Segmentation 1.2 Why You Should Read This Report 1.3 How This Report Delivers: Chapter Outline 1.4 Key Questions Answered by This Analytical Report 1.5 Who is This Report For? 1.6 Methodology 1.7 Frequently Asked Questions (FAQ) 1.8 Associated Visiongain Reports 1.9 About Visiongain
2. Introduction to Infusion Pumps 2.1 Types of Infusion 2.2 Types of Pumps 2.2.1 Gravity Controlled Infusion 2.2.2 Positive Displacement Pumps 2.2.3 Drip Rate Pumps 2.2.4 Volumetric Pumps 2.2.5 Syringe Pumps 2.2.6 Multi-Channel Pumps 2.2.7 Ambulatory Pumps 2.3 History of Infusion Pumps 2.4 What Clinical Settings Will Infusion Pumps Be Useful For? 2.4.1 Infusion Pumps for Diabetes 2.4.2 Infusion Pumps for Chemotherapy 2.4.3 Infusion Pumps for Analgesia 2.4.4 Infusion Pumps for Enteral Feeding 2.4.5 Other Uses for Infusion Pumps 2.5 Advantages and Disadvantages of Infusion Pumps
3. Infusion Pumps: World Market, 2015-2026 3.1 World Medical Devices Market, 2015-2026 3.2 Infusion Pump Market Definition 3.3 World Infusion Pumps Market, 2015 3.4 World Infusion Pumps Market Forecast, 2016-2026 3.4.1 The Infusion Pumps Market Forecast, 2015-2020 3.4.2 The Infusion Pumps Market Forecast, 2020-2026 3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders 3.6 How Will Segmental Market Shares Change to 2026? 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2026 3.7.1 Ageing Population and Rising Incidences of Chronic Diseases 3.7.2 Advancement in Infusion Pump Technologies 3.7.3 A Shift towards Home Care 3.7.4 Safety Risk and Stringent Approval Process
4. Leading National Markets, 2015-2026 4.1 Regional Breakdown of World Infusion Pumps Market, 2015 4.2 Infusion Pumps National Market Forecast, 2015-2026 4.2.1 How Will National Market Shares Change to 2026? 4.3 US Infusion Pumps Market, 2015-2026 4.3.1 US Medical Device Regulations, 2015-2026 4.3.2 US Infusion Pumps Market Forecast, 2015-2026 4.4 EU Infusion Pumps Market 2015 4.4.1 EU Medical Device Approval and Regulations 4.4.2 The EU Approval and Regulation System 4.4.3 Changes in the New EU Medical Device Regulations 4.4.4 Post Marketing Surveillance in the EU 4.4.5 EU Infusion Pumps Market Forecast, 2015-2026 4.4.6 How Will EU Market Shares Change to 2026? 4.4.7 German Infusion Pumps Market Forecast, 2015-2026 4.4.8 French Infusion Pumps Market Forecast, 2015-2026 4.4.9 UK Infusion Pumps Market Forecast, 2015-2026 4.4.10 Italian Infusion Pumps Market Forecast, 2015-2026 4.4.11 Spanish Infusion Pumps Market Forecast, 2015-2026 4.5 Japanese Infusion Pumps Market, 2015 4.5.1 Japan: Improved Approval Process 4.5.2 Japanese Infusion Pumps Market Forecast, 2015-2026 4.6 Chinese Infusion Pumps Market, 2015 4.6.1 Chinese Infusion Pumps Market Forecast, 2015-2026 4.6.2 China’s 12th Five-Year-Plan (2010-2015) 4.6.3 New Policies Favouring Domestically-Made Medical Devices 4.7 Indian Infusion Pumps Market 2015 4.7.1 Indian Infusion Pumps Market Forecast, 2015-2026 4.8 Brazilian Infusion Pumps Market, 2015 4.8.1 Brazilian Infusion Pumps Market Forecast, 2015-2026 4.9 South Korean Infusion Pumps Market, 2015 4.9.1 South Korean Infusion Pumps Market Forecast, 2015-2026 4.10 Russian Infusion Pumps Market, 2015 4.10.1 Russian Infusion Pumps Market Forecast, 2015-2026
5. Insulin Pumps Submarket, 2015-2026 5.1 Introduction to Insulin Pumps 5.2 Insulin in Insulin Pumps 5.2.1 Bolus Infusion 5.2.2 Basal Infusion 5.3 Advantages and Disadvantages of Insulin Pumps 5.4 Human Insulin and Analogues 5.5 Insulin Infusion Pumps Submarket, 2015 5.6 Insulin Pumps Submarket Regional Breakdown, 2015 5.7 Insulin Pumps Submarket: Sales Forecast, 2015-2026 5.8 Insulin Pumps Submarket: Sales Forecast, 2015-2020 5.9 Insulin Pumps Submarket: Sales Forecast, 2020-2026 5.10 Leading Products in Insulin Pumps Submarket, 2016 5.10.1 MiniMed (Medtronic) 5.10.2 OmniPod (Insulet Corporation) 5.10.3 OneTouch Ping (Animas Corporation) 5.10.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche) 5.10.5 t:Slim (Tandem Diabetes Care) 5.10.6 Animas Vibe (Animas Acquired by Johnson & Johnson) 5.10.7 DANA Diabecare IISG (SOOIL) 5.10.8 SpringZone (D. Medical Industries) 5.10.9 Cellnovo (Cellnovo) 5.10.10 V-Go (Valeritas) 5.11 Key Insulin Pumps Pipeline Products, 2016 5.11.1 Finesse Personal Insulin Patch (Johnson & Johnson) 5.11.2 SOLO MicroPump (Roche) 5.11.3 Artificial Pancreas (Juvenile Diabetes Research Foundation) 5.11.4 Freehand (MedSolve Technologies) 5.11.5 NanoPump (Debiotech) 5.11.6 PassPort (Altea Therapeutics) 5.11.7 NiliPatch (D. Medical Industries) 5.12 Insulin Pumps Submarket: Drivers and Restraints, 2015-2026 5.12.1 Increased Competition Drives Innovation 5.12.2 Collaborating to Address Unmet Needs 5.12.3 A Strong R&D Pipeline Will Drive the Market 5.12.4 Diabetes Globalisation: A Rapidly Increasing Incidence 5.13 Developed Economies: Increasing Adoption 5.14 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits 5.15 More Expensive Technology Presents a Challenge When Entering Emerging Markets 5.16 Security Risks with Insulin Pumps
6. Enteral Feeding Pumps Submarket, 2015-2026 6.1 Introduction to Enteral Feeding Pumps 6.1.1 Clinical Settings That May Require Enteral Feeding 6.1.2 Advantages and Disadvantages of Enteral Feeding 6.2 Delivery of Enteral Feeding 6.2.1 Tube Placements Used in Enteral Feeding 6.2.2 Enteral Feeding at Home 6.2.3 Enteral Feeding Pumps Submarket, 2015 6.2.4 Enteral Feeding Pumps Submarket Regional Breakdown, 2015 6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2026 6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2015-2020 6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2021-2026 6.4 Leading Products in Enteral Feeding Pump Submarket 2015 6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline) 6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific) 6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex /Moog) 6.4.4 APPLIX Vision (Fresenius Kabi) 6.4.5 MiniFlo (Fresenius Kabi) 6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia) 6.4.7 Sapphire (Q Core Medical) 6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien) 6.4.9 Other Notable Enteral Feeding Pumps 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2026 6.5.1 Cost-Effective, Portable and Safer Products Will Drive Growth 6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases 6.5.3 Increasing Demand for Homecare Solutions and Portability 6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2015 6.5.5 Introduction of ISO’s Standards for Small-Bore Connectors 6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue 6.5.7 Highly Competitive Market with High Barriers to Entry
7. Other Infusion Pumps Submarket, 2015-2026 7.1 Other Infusion Pumps Submarket Definition 7.2 Other Infusion Pumps Submarket, 2015 7.3 Other Infusion Pumps Submarket: Sales Forecast, 2015-2026 7.4 Chemotherapy Pumps 7.5 Advantages and Disadvantages of Chemotherapy Pumps 7.6 Leading Drugs in the Oncology Therapeutics Market, 2015 7.7 The Chemotherapy Pumps Market, 2016 7.8 Leading Products in Chemotherapy Pumps Market, 2016 7.8.1 Infusor Infusion Pump (Baxter) 7.8.2 CODMAN 3000 (Johnson & Johnson) 7.8.3 Optima MS (Fresenius Kabi) 7.8.4 CADD Legacy-1 (Smiths Medical) 7.8.5 Other Notable Chemotherapy Pumps 7.9 Chemotherapy Pumps Market: Drivers and Restraints, 2016-2026 7.10 Patient Controlled Analgesia (PCA) Pumps 7.10.1 Clinical Settings Where PCA Pumps Are Used 7.10.2 How Does a PCA Pump Work? 7.10.3 Advantages and Disadvantages of PCA Pumps 7.11 Narcotic Drugs 7.12 Leading Products in the PCA Pumps Market 2016 7.12.1 LifeCare PCA 7.0 with Hospira MedNet Software (Hospira) 7.12.2 Alaris PCA (CareFusion) 7.12.3 Baxter PCA II (Baxter) 7.12.4 Curlin PainSmart IOD Pain Management System (B.Braun) 7.12.5 CADD-Solis Infusion Pump (Smiths Medical) 7.12.6 Other Notable PCA Pumps 7.13 PCA Pumps Market: Drivers and Restraints, 2016-2026
8. Competing Technology Analysis, 2015-2026 8.1 Drug Delivery Technologies 8.2 Types of Technologies for Drug Delivery 8.2.1 Sustained/Controlled Release Systems 8.2.2 Injection 8.2.3 Needle Free Injections 8.2.4 Pulmonary, Buccal and Nasal Delivery 8.2.5 Pills and Capsules 8.3 World Drug Delivery Technologies Market, 2015 8.4 Drug Delivery Technologies Market Regional Breakdown, 2015 8.5 World Drug Delivery Technologies Market Forecast, 2015-2026 8.6 Key Drug Delivery Pipeline Products, 2016
9. Qualitative Analysis of the Infusion Pumps Market, 2015-2026 9.1 SWOT Analysis of World Infusion Pumps Market, 2015-2026 9.2 Strengths 9.2.1 Highly Accurate Dosing at Regular Intervals 9.2.2 Improved Quality of Life and Less Hospital Visits 9.2.3 Used in a Wide Range of Clinical Settings 9.3 Weaknesses 9.3.1 Safety Concerns Will Call for Stricter Regulation 9.3.2 Discomfort May Discourage Potential Users 9.3.3 Expensive Technologies May Restrain the Market 9.4 Opportunities 9.4.1 Emerging Economies Are Growing 9.4.2 Patient Demographics 9.4.3 High Demand for Technological Advancements 9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market 9.5 Threats 9.5.1 Poor Economic Conditions in Key Regions of the Market 9.5.2 Cost Effectiveness May Be Difficult to Prove 9.5.3 Regulatory Bodies Can Make Entry to Market Difficult 9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion 9.6 Porter’s Five Forces Analysis of the Infusion Pumps Market 9.6.1 Competitive Market Leaders [High] 9.6.2 Threat of New Entrants [Medium] 9.6.3 Power of Suppliers [Medium] 9.6.4 Bargaining Power of Buyers [High] 9.6.5 Threat of Substitutes [Medium]
10. Research Interview 10.1 Interview with Dr. Ann Blandford Professor of Human–Computer Interaction at UCL and Director of the UCL Institute of Digital Health 10.1.1 Safety and Practicality of the Infusion Pump 10.1.2 Market Potentials in the Insulin Pumps Market 10.1.3 Opportunities for Infusion Pumps Manufacturers 10.1.4 Future of Insulin Pumps Market 10.2 Interview with Professor Patricia Trbovich of the Institute of Health Policy, Management, and Evaluation and Her Colleagues Mark Fran and Sonia Pinkey of HumanEra 10.2.1 Safety and Practicality of the Infusion Pump 10.2.2 Opportunities for Infusion Pumps Manufacturers 10.2.3 Future of Insulin Pumps Market
11. Conclusion 11.1 Infusion Pumps: A Growing Industry 11.2 Current Look at the World Infusion Pumps Market, 2015 11.3 The Global Infusion Pumps Market: Driven or Restrained?
Appendix Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Report Evaluation Form
List of Figures Figure 1.1 Top Five National Infusion Pumps Market by Revenue, 2016 & 2026 Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2016 Figure 2.1 Positive Displacement Pump Mechanism Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) 2015-2026 Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn), 2015-2026 Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2015-2026 Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2015 Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2020 Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2026 Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2026 Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2015 Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2015 Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) by Region, 2015, 2020, and 2026 Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2015-2020, 2020-2026, and 2015-2026 Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2020 Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2026 Figure 4.7 US 65+ Population Forecast: Size (m), 2015-2026 Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.9 EU5 Infusion Pumps Market: Leading Countries by Revenue ($bn), 2015 Figure 4.10 EU5 Infusion Pumps Market: Leading Countries by Market Share (%), 2015 Figure 4.11 EU5 Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2015-2026 Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2015-2026 Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2015-2020, 2020-2026 and 2015-2026 Figure 4.14 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2020 Figure 4.15 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2026 Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) 2015-2026 Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2015-2026 Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) 2015-2026 Figure 4.23 China’s Historical Healthcare Expenditure ($bn), 2001-2010 Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010 and 2050 Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2015-2026 Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) 2015-2026 Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn), 2015-2026 Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2015 Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2015 Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2015 Figure 5.4 World Insulin Pumps Market: Market Shares (%) by Region, 2015 Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2015-2026 Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2016-2026 Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2015 Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2016 Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2015 Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Region, 2015 Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2015-2026 Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn), 2015-2026 Figure 7.2 Top 10 Oncology Pharmaceuticals: Revenues ($bn), 2015 Figure 7.3 Top 10 Oncology Pharmaceuticals: Market Shares (%), 2015 Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2016-2026 Figure 7.5 Routes of PCA Administration Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2016-2026 Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2015 Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2015 Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2015 Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2015 Figure 8.5 Global Drug Delivery Market Forecast: Revenue ($bn) , 2015-2026 Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage 2015 ($) Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2015-2026 Figure 9.3 Porter’s Five Forces Analysis of the Infusion Pumps Market, 2015-2026 Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2015 & 2026 Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2016-2026
List of Tables Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2026 Table 2.1 Four Types of Infusion Table 2.2 Advantages and Disadvantages of syringe pumps Table 2.3 Advantages and Disadvantages of Insulin Pumps Table 2.4 Advantages and Disadvantages of Infusion Pumps Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2015-2020 Table 3.1.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2021-2026 Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2026 Table 3.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2015-2020 Table 3.3.1 Market Shares (%) of Infusion Pumps by Market Segment 2021-2026 Table 3.4 Percentage of the Population Over 65 Years of Age, 2015-2026 Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2015 Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2015-2026 Table 4.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2015-2026 Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2015-2020, 2020-2026 and 2015-2026 Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2015, 2020, and 2026 Table 4.4.1Classification of Medical Devices in the United States Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.5.1 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.6 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2015-2020 Table 4.6.1 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2021-2026 Table 4.7 EU5 Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), Market Share (%) and CAGR (%), 2015-2026 Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2015-2020, 2020-2026 and 2015-2026 Table 4.9 EU5 Market Shares (%) of the European Infusion Pumps Market by Leading Countries 2015, 2020, and 2026 Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.10.1 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.11.1 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.12.1 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.13.1 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.14.1 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.15.1 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.16.1 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.17.1 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.18.1 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.19.1 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 4.20.1 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 5.1 Control of Insulin Delivery (Infusion Types and Methods) Table 5.2 Advantages and Disadvantages of Insulin Pumps Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2015 Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2015 Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 5.5.1 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 5.6 Leading Products in the Insulin Pumps Submarket, 2016 Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2016 Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2015 Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2016 Table 6.2 Types of Tubes Used in Enteral Feeding, 2016 Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2015 Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 6.4.1 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2015 Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2015 Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2015-2020 Table 7.1.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2021-2026 Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps Table 7.3 Oncology Pharmaceuticals: Revenue ($bn) and Market Shares (%), 2015 Table 7.4 Top 10 Oncology Pharmaceuticals: Key Facts Table 7.5 Leading Products in the Chemotherapy Pump Market, 2016 Table 7.6 Advantages and Disadvantages of PCA Pumps Table 7.7 Leading Products in the PCA Pumps Market, 2016 Table 7.8 Other Noticeable PCA Pumps Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2015 Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2015 Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2015-2020 Table 8.3.1 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2020-2026 Table 8.4 Key Pipeline Products for Oral Delivery, 2016 Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2016 Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2016 Table 9.1 SWOT Analysis of World Infusion Pumps Market 2015-2026 Table 9.2 Average Initial Costs Associated With Insulin Pump Use 2015 ($) Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage 2015 ($) Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2016
Abbott Nutrition Akas Medical Alcor Scientific Alkermes Allied Medical Altea Therapeutics Amsino International Animas Corporation Aradigm Asante B. Braun Baxter Bayer Healthcare Becton & Dickson & Co Bio-Med BMS Boston Scientific Corporation Calibra Medical Cardinal Health CareFusion Celgene Cellnovo Celsus Laboratories CeQur CME Medical Codman and Shurtleff Conmed Corporation Cook Medical Covidien D. Medical Industries Danone Nutricia Debiotech DePuy Disetronic Medical Systems DreaMed Diabetes Eli Lilly Emco Emisphere Fresenius Kabi GE Medical Generex Biotechnology Corporation Glycologic Hanraj Nayyar Medical India Hospira IBM I-Flow Insulet Corporation Intercell Johnson and Johnson Kimberly Clark Corporation Medingo Medsolve Technologies Medtronic Micrel Medical Devices Mindray Moog NeoDevices NeoMed Nestle Healthcare NiliMEDIX Novartis Noven Pharmaceuticals NovoNordisk Pacira Pharmaceuticals Philips Medical pSivida Corporation Q Core Medical Roche Sanofi Schiller Smith Medical SOOIL Symbios Medical Products Takeda Tandem Diabetics Care Tandem Diagnostics Terumo Medical Corporation Trivitron Valeritas Vectura Vishal Surgical WalkMed Inc Zevex
Organizations Mentioned Agência Nacional de Vigilância Sanitária (ANVISA) American Medical Devices and Diagnostic Association (AMDD) Center for Devices and Radiological Health (CDRH) Centres for Medicare and Medicaid Service (CMS) China Food and Drug Administration (CFDA) China’s National Health and Planning Commission (NHPC) Chinese Ministry of Science and Technology Government Accountability Office (GAO) Japanese Ministry of Health, Labour and Welfare (MHLW) Juvenile Diabetes Research Foundation Medical Devices Information & Technology Assistance Centre (MDITAC) Medicines and Healthcare products Regulatory Agency (MHRA) National Competent Authorities (NCAs) National Diabetes Education Program (NDEP) National Institute for Health and Clinical Excellence (NICE) National Medical Devices Authority (NMDA) NHS England Ningbo First Hospital Roszdravnadzor Sahlgrenska Academy Servicio Sanitario Nazionale (SSN) South Korean Ministry for Food and Drug Safety (MFDS) South Korean Ministry of Health and Welfare (MOHW) South Korean Ministry of Science, ICT and Future Planning (MSIP) South Korean Ministry of Trade, Industry and Energy (MOTIE) Único de Saúde (SUS) United Nations Population Division United States Food and Drug Administration (FDA) US Department of Health and Human Services World Bank World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for World Infusion Devices Market 2016-2026
Download sample pages
Complete the form below to download your free sample pages for World Infusion Devices Market 2016-2026
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain
It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.
“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain
Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.
“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain
The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.
